Daniel Feinberg

618 total citations
25 papers, 440 citations indexed

About

Daniel Feinberg is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Daniel Feinberg has authored 25 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Hematology. Recurrent topics in Daniel Feinberg's work include Multiple Myeloma Research and Treatments (5 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Daniel Feinberg is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Daniel Feinberg collaborates with scholars based in United States, China and Saudi Arabia. Daniel Feinberg's co-authors include Dana T. Graves, Leo McCluskey, A. Ortega, Carlos Rossa, Shawn J. Bird, Charles R. Cantor, Yubin Kang, Barry Paul, David C. Preston and Karen M. Weidenheim and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Journal of Bone and Mineral Research.

In The Last Decade

Daniel Feinberg

24 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Feinberg United States 12 169 70 65 64 63 25 440
Rosalie Veile United States 14 213 1.3× 66 0.9× 118 1.8× 88 1.4× 58 0.9× 32 647
Denise Lowe United States 14 100 0.6× 51 0.7× 62 1.0× 54 0.8× 134 2.1× 26 485
Sibel Oğuzkan Balcı Türkiye 13 115 0.7× 73 1.0× 59 0.9× 41 0.6× 28 0.4× 48 404
Lynda McGahan Canada 11 91 0.5× 34 0.5× 38 0.6× 46 0.7× 104 1.7× 29 495
Smriti Agrawal India 10 197 1.2× 54 0.8× 157 2.4× 43 0.7× 84 1.3× 38 606
Lauro José Gregianin Brazil 18 170 1.0× 67 1.0× 20 0.3× 39 0.6× 209 3.3× 66 665
Marlene Christina Nielsen Denmark 8 107 0.6× 33 0.5× 159 2.4× 59 0.9× 48 0.8× 12 386
R. Dreher Germany 7 138 0.8× 41 0.6× 88 1.4× 52 0.8× 47 0.7× 29 618
Spyros Batzios Greece 15 153 0.9× 34 0.5× 16 0.2× 62 1.0× 147 2.3× 42 609
Astrid Fabry Austria 8 117 0.7× 22 0.3× 68 1.0× 62 1.0× 29 0.5× 11 380

Countries citing papers authored by Daniel Feinberg

Since Specialization
Citations

This map shows the geographic impact of Daniel Feinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Feinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Feinberg more than expected).

Fields of papers citing papers by Daniel Feinberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Feinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Feinberg. The network helps show where Daniel Feinberg may publish in the future.

Co-authorship network of co-authors of Daniel Feinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Feinberg. A scholar is included among the top collaborators of Daniel Feinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Feinberg. Daniel Feinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feinberg, Daniel, et al.. (2025). CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy. Journal of Autoimmunity. 151. 103369–103369. 9 indexed citations
2.
Feinberg, Daniel, et al.. (2023). p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction. Cancer Research Communications. 3(5). 793–806. 2 indexed citations
3.
Wu, Jian, et al.. (2023). Inhibition of Sphingosine Kinase 2 Results in PARK2-Mediated Mitophagy and Induces Apoptosis in Multiple Myeloma. Current Oncology. 30(3). 3047–3063. 4 indexed citations
4.
Kang, Yubin, Pasupathi Sundaramoorthy, Cristina Gasparetto, et al.. (2022). Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma. Annals of Hematology. 102(2). 369–383. 11 indexed citations
5.
Feinberg, Daniel, et al.. (2022). Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells. Frontiers in Immunology. 13. 841299–841299. 14 indexed citations
6.
Cooper, William O., Nancy M. Lorenzi, Heather Davidson, et al.. (2021). Supporting the pursuit of professionalism during a crisis. BMJ Leader. 6(2). 104–109. 5 indexed citations
7.
Paul, Barry, et al.. (2020). Gamma Gap: A Point-of-Care Test That Correlates With Disease Burden and Treatment Response in Multiple Myeloma. JCO Oncology Practice. 16(8). e751–e757. 6 indexed citations
9.
Feinberg, Daniel, Barry Paul, & Yubin Kang. (2019). The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma. Cellular Immunology. 345. 103964–103964. 19 indexed citations
10.
Feinberg, Daniel, et al.. (2018). Chondrocytes Promote Vascularization in Fracture Healing Through a FOXO1-Dependent Mechanism. Journal of Bone and Mineral Research. 34(3). 547–556. 27 indexed citations
11.
Paul, Barry, Daniel Feinberg, Pasupathi Sundaramoorthy, J. Brice Weinberg, & Yubin Kang. (2018). Relationship of acquired resistance of myeloma cells to bortezomib with Lyn and Src induced inhibition of PP2A and effect of treatment with the tyrosine kinase inhibitor dasatinib.. Journal of Clinical Oncology. 36(15_suppl). 8047–8047. 2 indexed citations
12.
Lim, Jason, Kang I. Ko, Marcelo Mattos, et al.. (2017). TNFα contributes to diabetes impaired angiogenesis in fracture healing. Bone. 99. 26–38. 71 indexed citations
13.
Ortega, A., et al.. (2017). The Role of Forkhead Box 1 (FOXO1) in the Immune System: Dendritic Cells, T Cells, B Cells, and Hematopoietic Stem Cells. Critical Reviews in Immunology. 37(1). 1–13. 70 indexed citations
14.
Feinberg, Daniel, et al.. (2014). Soft tissue hemangioma with osseous extension: a case report and review of the literature. Skeletal Radiology. 44(4). 597–603. 6 indexed citations
15.
Feinberg, Daniel, David C. Preston, Jeremy M. Shefner, & Eric L. Logigian. (1999). Amplitude-dependent slowing of conduction in amyotrophic lateral sclerosis and polyneuropathy. Muscle & Nerve. 22(7). 937–940. 30 indexed citations
16.
McCluskey, Leo, Daniel Feinberg, Charles R. Cantor, & Shawn J. Bird. (1999). ?Pseudo-conduction block? in vasculitic neuropathy. Muscle & Nerve. 22(10). 1361–1366. 52 indexed citations
17.
McCluskey, Leo, Daniel Feinberg, & Carol A. Dolinskas. (1999). Suprascapular neuropathy related to a glenohumeral joint cyst. Muscle & Nerve. 22(6). 772–777. 13 indexed citations
18.
Feinberg, Daniel, David C. Preston, Jeremy M. Shefner, & Eric L. Logigian. (1999). Amplitude‐dependent slowing of conduction in amyotrophic lateral sclerosis and polyneuropathy. Muscle & Nerve. 22(7). 937–940.
19.
Kelley, Richard I., Daniel Feinberg, & Stanton Segal. (1989). Galactose-1-phosphate uridyl transferase in density-fractionated erythrocytes. Human Genetics. 82(2). 99–103. 6 indexed citations
20.
Feinberg, Daniel. (1970). PREVENTIVE THERAPY WITH SIBLINGS OF A DYING CHILD. Journal of the American Academy of Child Psychiatry. 9(4). 644–668. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026